Table 1.
Expression, immune response, clinical correlation and function of ANX2 in cancer
| Cancer tissue | Expression | Immune response | Clinical correlation | Function |
|---|---|---|---|---|
| Bone |
protein [110] |
|
|
Metastasis [110] |
| Brain |
protein [97,98] |
|
Diagnosis [98] |
|
| Breast |
mRNA [99] |
|
|
Chemoresistance, Growth, Metastasis [99,114-116,118] |
| Colon |
mRNA, protein [86,89,96] |
|
Prognosis [86] |
|
| Gastric |
protein [85] |
|
Prognosis [85] |
|
| Head and neck |
mRNA, protein [100][105-109] |
Ab [119,120] |
Prognosis [100] |
|
| Hematopoietic system |
mRNA [95] protein [68,91] |
|
|
Growth, Metastasis [68,91] |
| Kidney |
protein [84,101] |
|
Survival, Prognosis [101] |
Metastasis [121] |
| Liver |
mRNA, protein [88,90,92,93] |
|
Diagnosis, Prognosis [90,93,103] |
|
| Lung |
protein [82] |
Ab [122] |
|
Growth, Metastasis [117] |
| Ovary |
|
Ab [123] |
|
|
| Pancreas |
mRNA, protein [81,87] |
Ab [65,124] |
Survival, Prognosis [65,104] |
Chemoresistance, EMT, Metastasis [65,104] |
| Prostate |
protein [102,111-113] |
|
Prognosis [102] |
Growth, Metastasis [47,102] |
| Skin |
|
T cells [125] |
|
|
| Thyroid | mRNA [83,94] |